Epidemiology Insights and Forecast

Connect with Expert

The Epidemiology insights report provides an analysis of disease burden, characterized by disease definition, prevalence, incidence, diagnosed cases, severity, comorbidities, and clinical manifestations. Potential patient flow dynamics in disease burden are driven by shifts in demographic indicators and their correlation with age and gender distribution over time. Changes in the reported cases and long-term survival of patients may depend on diet, lifestyle, comorbid conditions, and the availability of interventions or therapies.

Key outcomes:

  • How significant are the incident/prevalent, diagnosed, and treatment-eligible patient pools for the specific country?
  • How will the patient dynamics change over a period with the availability of new interventions or therapies?
  • What are the patient segmentations by age, gender, severity level, comorbidities, line of therapies, etc.?
  • What is the relative size of patient segments and sub-populations?
  • How does the disease burden vary by country/ region?

Reports:

October 16, 2024

Market Outlook and Forecast

Relapsed or Refractory Mycosis Fungoides (MF) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Relapsed or Refractory Mycosis Fungoides (MF) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Relapsed or Refractory Mycosis Fungoides treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 13, 2024

Market Outlook and Forecast

Amblyopia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Amblyopia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Amblyopia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 11, 2024

Market Outlook and Forecast

Phelan-McDermid Syndrome (PMS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Phelan-McDermid Syndrome (PMS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential 22q13 deletion syndrome treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 2, 2024

Market Outlook and Forecast

Lymphocytopenia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Lymphocytopenia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Lymphopenia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 18, 2024

Market Outlook and Forecast

Pericarditis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Pericarditis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Pericarditis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

October 5, 2024

Market Outlook and Forecast

Moderate to Severe Chronic Hand Eczema – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Thelansis’s “Moderate to Severe Chronic Hand Eczema Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Moderate to Severe Chronic Hand Eczema treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Explore Reports

Need customize support?

Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.

Connect with Expert